UCLA professor Jesse Rissman said the left rostrolateral prefrontal cortex is important in accessing knowledge that was formed in the past and making decisions about it.
Research led by a UCLA scientist found that a new nerve stimulation therapy to increase blood flow could aid patients with the most common type of stroke up to 24 hours after onset.
Research Brief: Nearly 1 million people in the U.S. have MS, and treatments that can reverse the course of disease, rather than temporarily ease symptoms, are needed.
The brain cells, called astrocytes, previously thought to provide mainly nourishment and housekeeping functions for neurons, may help regulate the disorders, a UCLA study suggests.
Dr. David Sabatini, a Massachusetts Institute of Technology biologist and associate director of the Whitehead Institute for Biomedical Research, earned the 2018 Switzer Prize for his research into influences on cell growth.
UCLA’s Dr. Michael Gandal said that beyond the important new findings, he is even more optimistic about what the data will help researchers learn in the future.
Researchers found that lower activity of an enzyme that helps maintain cells’ health along with DNA damage were associated with worse cognitive performance, such as attention and motor skills.
The life scientists have provided the first cell “atlas” of the hippocampus — the part of the brain that helps regulate learning and memory — when it is affected by traumatic brain injury.
The $3.7 million, three-year grant will go toward research aimed to develop imaging technology that allows the recording of tens of thousands of neurons to better understand how the brain goes awry in disease.
A pioneer in her field, Dr. Linda Liau is only the second woman in the nation — and the first Asian-American woman — to chair an academic department of neurosurgery.
Neuroscientist Jack Feldman will explain the importance of the connections between breathing and the brain as he delivers UCLA’s 125th Faculty Research Lecture.
The idea for the project began 20 years ago, when UCLA professor Anne Andrews was researching serotonin and realized that the then-state-of-the-art methods for monitoring neurochemicals couldn’t provide data with sufficient quality.